2004 4050S1 11 Levin

Information about 2004 4050S1 11 Levin

Published on August 2, 2007

Author: Breezy

Source: authorstream.com

Content

Neonatal Adverse Events Associated with in utero SSRI/SNRI Exposure:  Neonatal Adverse Events Associated with in utero SSRI/SNRI Exposure Robert Levin, M.D. Medical Reviewer DNDP FDA Slide2:  SSRIs and SNRI:  SSRIs and SNRI Selective Serotonin Reuptake Inhibitors: fluoxetine, sertraline, paroxetine, paroxetine CR, fluvoxamine, citalopram Serotonin Norepinephrine Reuptake Inhibitor: venlafaxine, venlafaxine ER Objectives:  Objectives 1. Highlight language in SSRI/SNRI class labeling a) PRECAUTIONS- Pregnancy non-teratogenic section b) DOSAGE and ADMINISTRATION section 2. Provide rationale for proposing class labeling Sources of Information re: SSRI/SNRI & Neonatal AE:  Sources of Information re: SSRI/SNRI andamp; Neonatal AE Postmarketing reports (AERS) Retrospective studies Prospective studies Medical literature PRECAUTIONS- Pregnancy non-teratogenic:  PRECAUTIONS- Pregnancy non-teratogenic Neonates exposed to SSRI/SNRI late in 3rd trimester have developed AE requiring prolonged hospitalization, respiratory support, tube feeding AE may arise immediately upon delivery Respiratory distress, cyanosis, apnea, seizures, temperature instability, feeding difficulty, vomiting, hypoglycemia, hypotonia, hypertonia, hyperreflexia, tremor, jitteriness, irritability, and constant crying Precautions- Pregnancy (continued):  Precautions- Pregnancy (continued) AE reported are consistent with SSRI/SNRI discontinuation symptoms or direct toxic effects of the drug In some cases, neonatal adverse events are consistent with serotonin syndrome (see WARNINGS) Dosage and Administration:  Dosage and Administration When treating a pregnant woman with SSRI/SNRI during 3rd trimester, carefully consider potential risks and benefits Physician may consider tapering SSRI/SNRI late in the 3rd trimester Terms Used for Neonatal SSRI/SNRI Syndromes:  Terms Used for Neonatal SSRI/SNRI Syndromes - SRI Withdrawal - SRI Toxicity - Poor Neonatal Adaptation - Serotonergic Excess - Serotonergic CNS Adverse Effects - Serotonin Syndrome SSRI/SNRI Discontinuation Symptoms in Adults1 :  SSRI/SNRI Discontinuation Symptoms in Adults1 Dysequilibrium: dizziness, vertigo, ataxia GI: nausea, vomiting Flu-like: fatigue, lethargy, myalgia, chills Sensory disturbance: paresthesia, electric shock sensation Sleep disturbance: insomnia, vivid disturbing dreams Neuropsychiatric symptoms 1Schatzberg AF, et al. Serotonin reuptake inhibitor discontinuation syndrome: A hypothetical definition. J Clin Psychiatry 1997; 58 [suppl 7] 5-10. Neuropsychiatric SSRI/SNRI Discontinuation Symptoms in Adults:  Neuropsychiatric SSRI/SNRI Discontinuation Symptoms in Adults Anxiety, agitation, irritability, crying spells, hypomania, depressed mood, confusion, impaired memory, impaired concentration, slowed thinking, tremor Some AE may resemble symptoms of the patient’s illness Other neuropsychiatric symptoms may be new for the patient SSRI/SNRI Toxicity in Adults:  SSRI/SNRI Toxicity in Adults CNS andamp; Neuromuscular: Irritability, jitteriness, tremor, restlessness, anxiety, agitation, insomnia, dystonia, dyskinesia GI: nausea, vomiting, diarrhea Mason PJ, et al. Serotonin Syndrome. Presentation of 2 cases and review of the literature. Medicine 2000 Jul, 79(4): 201-9 Serotonin Syndrome in Adults:  Serotonin Syndrome in Adults CNS: convulsions, disorientation, cognitive impairment Neuromuscular: hypertonia, rigidity, myoclonus, hyperreflexia, paresthesia Autonomic Instability andamp; Temperature Instability: Respiratory distress, tachypnea, hyperthermia, temperature instability, rigors, chills, diaphoresis, tachycardia Mason PJ, et al. Serotonin Syndrome. Presentation of 2 cases and review of the literature. Medicine 2000 Jul, 79(4): 201-9 Similarities Between Neonatal AE & Adult Discontinuation Symptoms:  Similarities Between Neonatal AE andamp; Adult Discontinuation Symptoms Neonatal 'Withdrawal' Irritability, jitteriness, agitation, insomnia, poor feeding, crying AE onset: 10 to 36 hours Resolution: 1 to 14 days Adult Withdrawal Irritability, anxiety, agitation, insomnia, anorexia, GI distress AE onset: 24 to 72 hours Resolution: 1 to 14 days Similarities Between Neonatal AE & Toxicity in Adults:  Similarities Between Neonatal AE andamp; Toxicity in Adults Neonatal 'Toxicity' Jitteriness, insomnia, hypertonia, myoclonus, hyperreflexia, convulsions, temperature dysregulation, autonomic instability, tachypnea Onset: immediate to several hours Resolution: hours to weeks May have high serum SSRI/SNRI levels Adult Toxicity Jitteriness, insomnia, hypertonia, myoclonus, hyperreflexia, akathisia, convulsions, temperature dysregulation, autonomic instability, tachypnea, cognitive symptoms Onset: highly variable Resolution: hours to several days May have high serum SSRI/SNRI levels Exposure to SSRI During Pregnancy- Serotonergic Symptoms in Newborns:  Exposure to SSRI During Pregnancy- Serotonergic Symptoms in Newborns Prospective, non-randomized, controlled study; N=40 Pregnant women with Depression or Panic vs. controls Fluoxetine or citalopram (20-40 mg) through delivery Outcome Measures: AE, maternal and neonatal SSRI andamp; metabolite levels, monoamine levels, vital signs Specific AE Assessment of 7 serotonergic symptoms: myoclonus, tremor, rigidity, hyperreflexia, shivering, restlessness, incoordination Laine K et al. Arch Gen Psychiatry 2003 Jul Vol 60: 720-6 Findings of Laine Study:  Findings of Laine Study SSRI group: 4-fold increase in serotonergic symptom score during Days 1-4 Tremor, restlessness, rigidity Mean neonatal SSRI serum levels were in the usual adult range Symptom resolution correlated with decreasing serum SSRI level SSRI group had lower cord 5-HIAA concentration, indicating increased CNS serotonin activity Serotonergic symptom score correlated inversely with 5-HIAA concentration Slide18:  Difficulty in Interpreting Neonatal AE:  Difficulty in Interpreting Neonatal AE Confounded by psychiatric andamp; other medical illnesses, obstetric factors, concomitant medications, etc. Background rates of AE unknown SSRI/SNRI use in pregnant women unknown Limited data from cases (maternal andamp; gestational age, timing of AE onset andamp; resolution, serum drug levels, duration andamp; doses of SSRI/SNRI Rx, etc). Limited repertoire of neonatal behaviors Overlap of SSRI/SNRI WD andamp; Toxicity symptoms Rationale for Proposing Class Labeling:  Rationale for Proposing Class Labeling Neonatal AE associated with SSRI/SNRI exposure during 3rd trimester have been reported for all drugs in the class AE are consistent with SSRI/SNRI discontinuation symptoms or direct toxic effects of drug Some neonatal AE are serious requiring special care Clinicians need to be aware of the potential for development of these neonatal AE Awareness could impact management (prevention, diagnosis, treatment) Treating Depression During Pregnancy:  Treating Depression During Pregnancy Morbidity of depression (mother andamp; neonate) Prevalence of depression during pregnancy: 10% to 16% Clinicians and patient can weigh potential risks andamp; benefits for mother and neonate when deciding upon treatment Might reduce risk of neonatal SSRI/SNRI exposure by tapering near term; might reduce the risk of depression relapse by restarting SSRI/SNRI upon delivery1 Lack of consensus about interpretation and management of these neonatal AE Controlled trials are needed in this important field Wisner et al. Pharmacologic Treatment of Depression During Pregnancy. JAMA 1999, Vol. 282 (13): 1264-9 Status of Proposed SSRI/SNRI Class Labeling :  Status of Proposed SSRI/SNRI Class Labeling Labeling for paroxetine, paroxetine CR, venlafaxine, venlafaxine ER, citalopram, and fluvoxamine include the new class labeling The sponsor of fluoxetine has accepted the class labeling The Division is having discussions with the sponsor of sertraline

Related presentations


Other presentations created by Breezy

Plant Anatomy
03. 01. 2008
0 views

Plant Anatomy

Learning Long Division
15. 06. 2007
0 views

Learning Long Division

ADO Net
24. 10. 2007
0 views

ADO Net

Ch 2 Chemistry of Life
05. 01. 2008
0 views

Ch 2 Chemistry of Life

REORGANIZATION
27. 09. 2007
0 views

REORGANIZATION

Enhanced Fujita Scale 6 23 04
05. 10. 2007
0 views

Enhanced Fujita Scale 6 23 04

severe convection punkka
07. 10. 2007
0 views

severe convection punkka

lsad07 psp
09. 10. 2007
0 views

lsad07 psp

idioms1
10. 10. 2007
0 views

idioms1

SabadosCiencia2006
13. 10. 2007
0 views

SabadosCiencia2006

Rousset EID06
19. 10. 2007
0 views

Rousset EID06

TheodoreRoosevelt
22. 10. 2007
0 views

TheodoreRoosevelt

Timss
17. 10. 2007
0 views

Timss

Wynn ASA 2000
04. 10. 2007
0 views

Wynn ASA 2000

aas strom
29. 08. 2007
0 views

aas strom

element connections
29. 08. 2007
0 views

element connections

hwr clustering
29. 08. 2007
0 views

hwr clustering

Pov map 20060717 1
29. 11. 2007
0 views

Pov map 20060717 1

CONSTRUCTING BUD VASES ADN BOWS
11. 12. 2007
0 views

CONSTRUCTING BUD VASES ADN BOWS

nobel talk
15. 10. 2007
0 views

nobel talk

18 FOSIS
24. 10. 2007
0 views

18 FOSIS

Lec 08 FO1 06 Urbanisation
01. 11. 2007
0 views

Lec 08 FO1 06 Urbanisation

America vs The World
22. 10. 2007
0 views

America vs The World

Vasco Da Gama Slide Show
07. 11. 2007
0 views

Vasco Da Gama Slide Show

Fliess
15. 11. 2007
0 views

Fliess

01 threat
19. 11. 2007
0 views

01 threat

Konsolen
21. 11. 2007
0 views

Konsolen

the dancers
23. 11. 2007
0 views

the dancers

Probil
26. 11. 2007
0 views

Probil

UNE Benz
27. 11. 2007
0 views

UNE Benz

Galaxies
29. 08. 2007
0 views

Galaxies

DB2 XML DatabaseFINAL
23. 10. 2007
0 views

DB2 XML DatabaseFINAL

akzonobel
15. 10. 2007
0 views

akzonobel

ilana
29. 08. 2007
0 views

ilana

lauter
07. 11. 2007
0 views

lauter

GradSch GPOs
04. 10. 2007
0 views

GradSch GPOs

PHYS402 01
16. 10. 2007
0 views

PHYS402 01

cry beloved
02. 08. 2007
0 views

cry beloved

curtis
02. 08. 2007
0 views

curtis

Chaplet of Divine Mercy
02. 08. 2007
0 views

Chaplet of Divine Mercy

CS583 opinion mining
02. 08. 2007
0 views

CS583 opinion mining

A TIME FOR ANDREW Pres 2
02. 08. 2007
0 views

A TIME FOR ANDREW Pres 2

arthur powerpoint 11 20 03
02. 08. 2007
0 views

arthur powerpoint 11 20 03

cheryl toner ific
02. 08. 2007
0 views

cheryl toner ific

bats
02. 08. 2007
0 views

bats

23 stavros thurs
02. 08. 2007
0 views

23 stavros thurs

aas04 jeff
29. 08. 2007
0 views

aas04 jeff

moustakis
29. 08. 2007
0 views

moustakis

irsurveys07
29. 08. 2007
0 views

irsurveys07

venice oct03
29. 08. 2007
0 views

venice oct03

Office of Homeleand Security
29. 10. 2007
0 views

Office of Homeleand Security

agn presentation 102106
29. 08. 2007
0 views

agn presentation 102106

ReginaSchulteLadbeck 042104
29. 08. 2007
0 views

ReginaSchulteLadbeck 042104

Weingarten
03. 01. 2008
0 views

Weingarten

Presentation NASDAQ
24. 02. 2008
0 views

Presentation NASDAQ

nov retail ebony
24. 02. 2008
0 views

nov retail ebony

APAsymp04AIDMAN
02. 08. 2007
0 views

APAsymp04AIDMAN

Ray Flores Roadmap
04. 03. 2008
0 views

Ray Flores Roadmap

Beloved
02. 08. 2007
0 views

Beloved

Konstantinidis
29. 09. 2007
0 views

Konstantinidis

Qin and Han Dynasties
25. 03. 2008
0 views

Qin and Han Dynasties

andy powell presentation
02. 08. 2007
0 views

andy powell presentation

arena rome minier
13. 11. 2007
0 views

arena rome minier

Presentation010605
10. 04. 2008
0 views

Presentation010605

03edclark lecture
13. 04. 2008
0 views

03edclark lecture

richard mushotzky
29. 08. 2007
0 views

richard mushotzky

Lawrence D Boston 2006
14. 04. 2008
0 views

Lawrence D Boston 2006

DMCH13
16. 04. 2008
0 views

DMCH13

ERates
17. 04. 2008
0 views

ERates

JHAN 14
18. 04. 2008
0 views

JHAN 14

4884061 firstfileFILE
22. 04. 2008
0 views

4884061 firstfileFILE

ppt26
23. 12. 2007
0 views

ppt26

Operations
28. 04. 2008
0 views

Operations

CH10 Outline
07. 04. 2008
0 views

CH10 Outline

CIM research
30. 04. 2008
0 views

CIM research

komossa
29. 08. 2007
0 views

komossa

ieee sp 2004
18. 06. 2007
0 views

ieee sp 2004

icws 2006 3
18. 06. 2007
0 views

icws 2006 3

ICTP intro
18. 06. 2007
0 views

ICTP intro

human mating beh 2005
18. 06. 2007
0 views

human mating beh 2005

IMDS CIESP
14. 11. 2007
0 views

IMDS CIESP

welch adv camp july05
02. 10. 2007
0 views

welch adv camp july05

Glycosylation
15. 06. 2007
0 views

Glycosylation

Making a Story Board
15. 06. 2007
0 views

Making a Story Board

Story Literary Elements
15. 06. 2007
0 views

Story Literary Elements

Life Cycle of Plants and Animals
15. 06. 2007
0 views

Life Cycle of Plants and Animals

Session1Alila
02. 11. 2007
0 views

Session1Alila

beetleborers
02. 01. 2008
0 views

beetleborers

2006 IADB
10. 10. 2007
0 views

2006 IADB

robo wk1
03. 01. 2008
0 views

robo wk1

Rosemary Panama
22. 10. 2007
0 views

Rosemary Panama

ec06nicapan
25. 10. 2007
0 views

ec06nicapan

Allies Pre Training Module
02. 08. 2007
0 views

Allies Pre Training Module

Carmona
30. 12. 2007
0 views

Carmona

TheSuccessofSingapor e2006
27. 03. 2008
0 views

TheSuccessofSingapor e2006

Advisory Board Presentation
02. 08. 2007
0 views

Advisory Board Presentation

Cameron SAS44 A Century of OA
27. 02. 2008
0 views

Cameron SAS44 A Century of OA

dubrovnik
16. 10. 2007
0 views

dubrovnik

sprfett
07. 01. 2008
0 views

sprfett

mccune albright syndrome
15. 10. 2007
0 views

mccune albright syndrome

michael soendermann 2007
18. 10. 2007
0 views

michael soendermann 2007

astro12Summer12
29. 08. 2007
0 views

astro12Summer12

familyweek1
19. 02. 2008
0 views

familyweek1